</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#e8e8e8" bgcolor="#e8e8e8">
CB Partner Webinar ANIVIVE {{webinarspromoemail2::client_only_logo}} {{webinarspromoemail2::client_only_logo_self_hosted}} {{webinarspromoemail2::client_only_logo_alt}} {{webinarspromoemail2::client_only_logo_width}} {{webinarspromoemail2::client_only_logo_custom_css}} {{webinarspromoemail2::client_color}} {{webinarspromoemail2::client_color_darker}} Advances in Canine Lymphoma {{webinarspromoemail2::race_approved}} {{webinarspromoemail2::credit_hours}} {{webinarspromoemail2::on_demand}} September 28, 2021 at 8:00 PM {{webinarspromoemail2::remove_webinar_date_and_time_1}} {{webinarspromoemail2::webinar_date_and_time_2}} {{webinarspromoemail2::remove_webinar_date_and_time_2}} {{webinarspromoemail2::webinar_date_and_time_3}} {{webinarspromoemail2::remove_webinar_date_and_time_3}} ET 1{nbs}HR The Role of Primary Care{br}Veterinarians {amp} Going Beyond{nbs}Steroids REGISTER NOW https://event.on24.com/wcc/r/3387426/3A7BE851F4CCB7EC5513D8E0B6A5A705 {{webinarspromoemail2::header_background_image_none}} {{webinarspromoemail2::header_background_image_1}} {{webinarspromoemail2::header_background_image_2}} {{webinarspromoemail2::header_background_image_3}} {{webinarspromoemail2::header_background_image_4}} true {{webinarspromoemail2::header_background_image_6}} {{webinarspromoemail2::supported_by}} /uploads/092821_webinar_partner_anivive_email_sponsor_logo_2_x-b6357c5bef2fc4e1bc2ff47b3a37d7a2.jpg {{webinarspromoemail2::client_logo_self_hosted}} 72 {{webinarspromoemail2::client_logo_alt}} {{webinarspromoemail2::client_logo_url}} {{webinarspromoemail2::place_logos_below_content}} true /uploads/072121_webinar_partner_anivive_email_speaker_clifford_2_x-a6bafeed06213b3f66201affdc71f1ae.jpg {{webinarspromoemail2::speaker_image_self_hosted_1}} Craig Clifford DVM, MS, DACVIM (Oncology) /uploads/092821_webinar_partner_anivive_email_speaker_galligher_2_x-996f013775112499d67201f532f99dda.jpg {{webinarspromoemail2::speaker_image_self_hosted_2}} Kimberley Galligher VMD {{webinarspromoemail2::speaker_image_3}} {{webinarspromoemail2::speaker_image_self_hosted_3}} {{webinarspromoemail2::speaker_name_3}} {{webinarspromoemail2::speaker_title_3}} {{webinarspromoemail2::speaker_image_4}} {{webinarspromoemail2::speaker_image_self_hosted_4}} {{webinarspromoemail2::speaker_name_4}} {{webinarspromoemail2::speaker_title_4}} {{webinarspromoemail2::speaker_image_5}} {{webinarspromoemail2::speaker_image_self_hosted_5}} {{webinarspromoemail2::speaker_name_5}} {{webinarspromoemail2::speaker_title_5}} {{webinarspromoemail2::speaker_image_6}} {{webinarspromoemail2::speaker_image_self_hosted_6}} {{webinarspromoemail2::speaker_name_6}} {{webinarspromoemail2::speaker_title_6}} {{webinarspromoemail2::place_speakers_below_content}} Primary care teams are often at the forefront of not only diagnosing but also treating canine lymphoma. Find out how we can maximize our role in treating these patients—from diagnosis and phenotyping to collaborating with specialists on compassionate communications with owners about their options—and how a new class of drugs is making primary care teams more powerful than ever in the fight against{nbs}lymphoma. {{webinarspromoemail2::inside_the_webinar_2}} {{webinarspromoemail2::inside_the_webinar_3}} Techniques to diagnose, stage, and grade canine lymphoma Which diagnostic tests inform patient{nbh}specific treatment protocols How SINE technology, the novel mechanism in LAVERDIA{nbh}CA1, works Where LAVERDIA{nbh}CA1 may fit in at your practice and how it differs from multiagent{nbs}chemotherapy Best practices for collaborating with a veterinary oncologist on patient{nbs}care {{webinarspromoemail2::what_youll_learn_6}} Be ready when that next lymphoma{br}case enters your exam{nbs}room. SAVE YOUR SEAT NOW This program is pending approval for 1 hour of CE credit{br}in the jurisdictions that recognize RACE{nbs}approval.
Advances in Canine Lymphoma
Advances in Canine Lymphoma
The Role of Primary Care{br}Veterinarians {amp} Going Beyond{nbs}Steroids
Produced by Clinician's Brief & ANIVIVE
September 28, 2021
08:00 PM ET (1{nbs}HR)
REGISTER NOW
REGISTER NOW
Produced by
Sponsored by
 
Clinician's Brief
{{webinarspromoemail2::client_logo_alt}}
 
Speakers
Craig Clifford
DVM, MS, DACVIM (Oncology)
Kimberley Galligher
VMD
Inside the Webinar
Primary care teams are often at the forefront of not only diagnosing but also treating canine lymphoma. Find out how we can maximize our role in treating these patients—from diagnosis and phenotyping to collaborating with specialists on compassionate communications with owners about their options—and how a new class of drugs is making primary care teams more powerful than ever in the fight against{nbs}lymphoma.
What you'll learn
  • Techniques to diagnose, stage, and grade canine lymphoma
  • Which diagnostic tests inform patient{nbh}specific treatment protocols
  • How SINE technology, the novel mechanism in LAVERDIA{nbh}CA1, works
  • Where LAVERDIA{nbh}CA1 may fit in at your practice and how it differs from multiagent{nbs}chemotherapy
  • Best practices for collaborating with a veterinary oncologist on patient{nbs}care
Be ready when that next lymphoma{br}case enters your exam{nbs}room.
SAVE YOUR SEAT NOW
SAVE YOUR SEAT NOW
This program is pending approval for 1 hour of CE credit{br}in the jurisdictions that recognize RACE{nbs}approval.
Produced by
Sponsored by
 
Clinician's Brief
{{webinarspromoemail2::client_logo_alt}}
 
</head> <body style="-ms-text-size-adjust:100%;-webkit-text-size-adjust:100%;margin:0;min-width:100%;padding:0;width:100%" data-bg-color="#e8e8e8" bgcolor="#e8e8e8">
Advances in Canine Lymphoma
Advances in Canine Lymphoma
The Role of Primary Care{br}Veterinarians {amp} Going Beyond{nbs}Steroids
Produced by Clinician's Brief & ANIVIVE
September 28, 2021
08:00 PM ET (1{nbs}HR)
REGISTER NOW
REGISTER NOW
Produced by
Sponsored by
 
Clinician's Brief
{{webinarspromoemail2::client_logo_alt}}
 
Speakers
Craig Clifford
DVM, MS, DACVIM (Oncology)
Kimberley Galligher
VMD
Inside the Webinar
Primary care teams are often at the forefront of not only diagnosing but also treating canine lymphoma. Find out how we can maximize our role in treating these patients—from diagnosis and phenotyping to collaborating with specialists on compassionate communications with owners about their options—and how a new class of drugs is making primary care teams more powerful than ever in the fight against{nbs}lymphoma.
What you'll learn
  • Techniques to diagnose, stage, and grade canine lymphoma
  • Which diagnostic tests inform patient{nbh}specific treatment protocols
  • How SINE technology, the novel mechanism in LAVERDIA{nbh}CA1, works
  • Where LAVERDIA{nbh}CA1 may fit in at your practice and how it differs from multiagent{nbs}chemotherapy
  • Best practices for collaborating with a veterinary oncologist on patient{nbs}care
Be ready when that next lymphoma{br}case enters your exam{nbs}room.
SAVE YOUR SEAT NOW
SAVE YOUR SEAT NOW
This program is pending approval for 1 hour of CE credit{br}in the jurisdictions that recognize RACE{nbs}approval.
Produced by
Sponsored by
 
Clinician's Brief
{{webinarspromoemail2::client_logo_alt}}